Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
Recruiting now · Not applicable
Conditions studied: HIV Infections
In brief
Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.
Key facts
- Study ID
- NCT06370780
- Run by
- University of California, Los Angeles
- People needed
- 1000
- Starts
- 2024-02-09
- Expected to finish
- 2028-04-30
- Last updated by the study team
- 2025-10-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Have access to a personal smartphone device;
- Over 18 years of age;
- Speak English or Spanish;
- Living with HIV
- Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression;
- Active substance use or mental health disorder;
- Willing and able to provide written informed consent to take part in the study.
You may not qualify if…
- Unwilling or unable to provide reliable contact information;
- Unwilling to provide blood sample for HIV virology testing;
- Living with HIV and virally suppressed and not at risk of becoming unsuppressed in the near future.
Where it is running
- University of California, Los Angeles — Los Angeles, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.